KarX-EC, KarX-EC, KarX-EC, KarXT, KarXT, KarX-EC, KarXT, KarXT
CN012-0025
Phase 3 small_molecule active
Quick answer
KarX-EC, KarX-EC, KarX-EC, KarXT, KarXT, KarX-EC, KarXT, KarXT for Agitation Associated with Alzheimer’s Disease is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Agitation Associated with Alzheimer’s Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active